ONESOURCE SPECIALTY PHARMA
|
The Current P/S Ratio of ONESOURCE SPECIALTY PHARMA is 12.99.
| Share Price | ₹1,610.8 | Jul 08,2026 |
| Market Cap | ₹18,459.8 Cr | |
| Sales-TTM | ₹1,421.6 Cr | TTM-Consolidated Results |
| Price/Sales | 12.99x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of ONESOURCE SPECIALTY PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹18,459.8 Cr] as on Jul 08,2026
(/) Sales [ ₹1,421.6 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 12.99x ]
Thus, for ONESOURCE SPECIALTY PHARMA , the investors are currently willing to pay '12.99 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ONESOURCE SPECIALTY PHARMA !
The chart below summarizes the trend in P/S Ratio of ONESOURCE SPECIALTY PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of ONESOURCE SPECIALTY PHARMA
PS Ratio Performance Analysis for ONESOURCE SPECIALTY PHARMA
- ONESOURCE SPECIALTY PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2022 averaged 3.46x.
- ONESOURCE SPECIALTY PHARMA 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 4 fiscal years, ONESOURCE SPECIALTY PHARMA 's p/e ratio peaked in Mar2025 at 13.84x.
- ONESOURCE SPECIALTY PHARMA 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does ONESOURCE SPECIALTY PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| ONESOURCE SPECIALTY PHARMA | 1,421.6 | 12.99 | 18,459.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.75 | 452,982.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 16.98 | 179,361.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 11.78 | 164,737.0 |
| CIPLA LTD | 28,162.6 | 4.11 | 115,655.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.34 | 112,573.0 |
| MANKIND PHARMA LTD | 14,277.6 | 7.20 | 102,795.0 |
| LUPIN LTD | 27,958.0 | 4.02 | 112,363.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.22 | 114,613.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.66 | 89,580.6 |
| LAURUS LABS LTD | 6,812.9 | 11.65 | 79,403.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ONESOURCE SPECIALTY PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.66x |
| Max industry PS | 16.98x |
| Median industry PS | 7.20x |
| Average industry PS | 7.88x |
You may also like the below Video Courses